Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Doris Peterkin"'
Autor:
Steven J Isakoff, Nadine M. Tung, Jun Yin, Nabihah Tayob, Joanne Parker, Julie Rosenberg, Aditya Bardia, Laura Spring, Hannah Park, Maya Collins, William T. Barry, Mariano Severgnini, Doris Peterkin, Sara M. Tolaney
Publikováno v:
Cancer Research. 82:P2-14
Background: Immunotherapy with checkpoint inhibition is active in mTNBC. Both pembrolizumab and atezolizumab are FDA approved for programmed cell death ligand 1 positive (PDL1+) mTNBC. Vaccines may further induce host immune response and enhance ther
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b1a38ab641065a2ec95752c86f0cab67
https://doi.org/10.1158/1538-7445.sabcs21-p2-14-17
https://doi.org/10.1158/1538-7445.sabcs21-p2-14-17
Autor:
Hatem Soliman, Leif W. Ellisen, Doris Peterkin, Sylvia Adams, Sara M. Tolaney, Hannah Park, Elena F. Brachtel, Joanne Parker, Steven J. Isakoff, Mariano Severgnini, Jiani Hu, William T. Barry, Lorenzo Trippa, Rachel Deering, Nadine Tung
Publikováno v:
Cancer Research. 80:P3-09
Background: eTNBC remains at high risk for recurrence despite modern (neo)adjuvant chemotherapy. Immunotherapy with checkpoint inhibition is active in early and metastatic TNBC, and vaccines may further induce host immune response. PVX-410 (PVX, Onco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d413c61fd418b4bd7bc8f784a376fd2
https://doi.org/10.1158/1538-7445.sabcs19-p3-09-15
https://doi.org/10.1158/1538-7445.sabcs19-p3-09-15
Autor:
Ajay K. Nooka, Jonathan L. Kaufman, Michael Luhua Wang, Andrew Yee, Noopur Raje, Paul G. Richardson, Jooeun Bae, Doris Peterkin
Publikováno v:
JAMA oncology. 4(12)
IMPORTANCE: Increasing evidence suggests the significance of the role of the immune system in the progression of smoldering multiple myeloma (SMM) to symptomatic multiple myeloma (MM). Boosting the immune system via vaccination in the earlier, asympt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c84b8e9f97d8d10d940eae4ba558287
https://pubmed.ncbi.nlm.nih.gov/30128502
https://pubmed.ncbi.nlm.nih.gov/30128502
Autor:
Leif W. Ellisen, Hatem Soliman, Karleen Habin, Doris Peterkin, Steven J. Isakoff, Nadine Tung, William T. Barry, Sara M. Tolaney, Mariano Severgnini, Sylvia Adams, Louisa J Bauer, Elena F. Brachtel
Publikováno v:
Journal of Clinical Oncology. 35:TPS1126-TPS1126
TPS1126 Background: Stage 2-3 triple negative breast cancer (TNBC) remains at high risk for recurrence despite modern adjuvant therapy. An important role for the immune system in TNBC has recently emerged. Tumor infiltrating lymphocytes (TILs) are co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62f5d8fbd81cbfd2cdbdbd94b77ec0e5
https://doi.org/10.1200/jco.2017.35.15_suppl.tps1126
https://doi.org/10.1200/jco.2017.35.15_suppl.tps1126
Autor:
Ajay K Nooka, Michael Wang, Andrew J. Yee, Sheeba K. Thomas, Elizabeth K. O'Donnell, Jatin J. Shah, Jonathan L. Kaufman, Doris Peterkin, Sagar Lonial, Paul G. Richardson, Noopur Raje
Publikováno v:
Blood. 128:2124-2124
Introduction: PVX-410 Multi-Peptide Vaccine (OncoPep, Inc.) is being developed for the treatment of SMM. PVX-410 consists of 4 human leukocyte antigen-A2 (HLA-A2), synthetic 9-mer peptides from unique regions of 3 multiple myeloma (MM)-associated ant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b5a27b6c8eb6cee6da0e74e385ce3d5f
https://doi.org/10.1182/blood.v128.22.2124.2124
https://doi.org/10.1182/blood.v128.22.2124.2124